Seguir
GRAHAM B JONES
GRAHAM B JONES
DIRECTOR OF INNOVATION AT NOVARTIS AG
Dirección de correo verificada de novartis.com - Página principal
Título
Citado por
Citado por
Año
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
SA Berkowitz, JR Engen, JR Mazzeo, GB Jones
Nature Reviews Drug Discovery 11 (7), 527-540, 2012
6302012
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
LC Kourtis, OB Regele, JM Wright, GB Jones
NPJ digital medicine 2 (1), 9, 2019
3592019
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 399 (10320), 143, 2022
2942022
Surface functionalization of gold nanoparticles using hetero-bifunctional poly (ethylene glycol) spacer for intracellular tracking and delivery
D Shenoy, W Fu, J Li, C Crasto, G Jones, C DiMarzio, S Sridhar, M Amiji
International journal of nanomedicine 1 (1), 51-57, 2006
2892006
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer
WK Oh, PW Kantoff, V Weinberg, G Jones, BI Rini, MK Derynck, R Bok, ...
Journal of clinical Oncology 22 (18), 3705-3712, 2004
1692004
A systematic genomewide linkage study in 353 sib pairs with schizophrenia
NM Williams, N Norton, H Williams, B Ekholm, ML Hamshere, Y Lindblom, ...
The American journal of human genetics 73 (6), 1355-1367, 2003
1462003
Preoperative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective UK database of 8820 patients
RP Sutcliffe, M Hollyman, J Hodson, G Bonney, RS Vohra, EA Griffiths, ...
Hpb 18 (11), 922-928, 2016
1432016
π stacking effects in asymmetric synthesis
GB Jones, BJ Chapman
Synthesis 1995 (05), 475-497, 1995
1361995
A2A adenosine receptor gene deletion or synthetic A2A antagonist liberate tumor-reactive CD8+ T cells from tumor-induced immunosuppression
J Kjaergaard, S Hatfield, G Jones, A Ohta, M Sitkovsky
The Journal of Immunology 201 (2), 782-791, 2018
1322018
Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo
KJ Starkey, A Janezic, G Jones, N Jordan, G Baker, M Ludgate
Journal of Molecular Endocrinology 30 (3), 369-380, 2003
1232003
Annulation Strategies for Benzo[b]fluorene Synthesis:  Efficient Routes to the Kinafluorenone and WS-5995 Antibiotics
G Qabaja, GB Jones
The Journal of Organic Chemistry 65 (21), 7187-7194, 2000
1192000
Electronic control of the Bergman cyclization: the remarkable role of vinyl substitution
GB Jones, PM Warner
Journal of the American Chemical Society 123 (10), 2134-2145, 2001
1122001
Designed enediyne antitumor agents
GB Jones, FS Fouad
Current pharmaceutical design 8 (27), 2415-2440, 2002
1092002
π Shielding in organic synthesis
GB Jones
Tetrahedron 57 (38), 7999-8016, 2001
1072001
Tetracycline compounds having target therapeutic activities
SB Levy, M Draper, ML Nelson, G Jones
1052003
Cultural diversity drives innovation: empowering teams for success
G Jones, BC Chace, J Wright
international Journal of innovation science 12 (3), 323-343, 2020
1032020
Population-based cohort study of outcomes following cholecystectomy for benign gallbladder diseases
Journal of British Surgery 103 (12), 1704-1715, 2016
1022016
Reductive cleavage of tert-butyldimethylsilyl ethers by diisobutylaluminum hydride
EJ Corey, GB Jones
The Journal of Organic Chemistry 57 (3), 1028-1029, 1992
991992
Methods of using substituted tetracycline compounds to modulate RNA
SB Levy, M Draper, ML Nelson, G Jones
US Patent 8,173,624, 2012
942012
Decarboxylation of indole-2-carboxylic acids: improved procedures
GB Jones, BJ Chapman
The Journal of Organic Chemistry 58 (20), 5558-5559, 1993
931993
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20